EUVIMEDAtklāt EUVIMED
Systematische ÜbersichtOpen access · CC BY-NC-ND 4.0

1 g/h magnesium sulfate maintenance for eclampsia prevention is enough

Alessandro Petrecca iD, Benedetta Bina, Tullio Ghi iD, Vincenzo Berghella

Acta Obstetricia et Gynecologica Scandinavica · 2026-05 · 105 (5) · 771-777

DOI: 10.1111/aogs.70205 ↗

At a glance

Systematische Übersicht in Acta Obstetricia et Gynecologica Scandinavica, published online on 2026-04-08. Written by Alessandro Petrecca and 3 co-authors. Institution: Department of Woman and Child Health and Public Health Sciences, Fondazione Policlinico A. Gemelli IRCSS, Catholic University of the Sacred Heart, Ro…. Major MEDLINE topics: Magnesium Sulfate, Eclampsia, Anticonvulsants. 15 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktsSubjectsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

We conducted two systematic reviews including only randomized controlled trials (RCTs) comparing magnesium sulfate vs placebo/no treatment, as well as 2 g/h vs 1 g/h magnesium sulfate maintenance regimens for prevention of eclampsia. Medline, Cochrane Library, EMBASE, PubMed Central, Scopus, ClinicalTrial.gov were electronically searched from their inception to February 2025. In the five RCTs comparing magnesium sulfate vs placebo/no treatment, a 2‐g maintenance dose was used in two RCTs including 176 pregnancies, while a 1 g maintenance dose was used in three RCTs including 5447 pregnancies. Eclampsia incidence was 0.57% with the 2 g/h regimen and 0.76% with the 1 g/h regimen (OR 1.33, 95% CI: 0.18–9.60), while maternal side effects were significantly higher in the 2 g/h regimen (67% vs 22%, OR 7.05, 95% CI: 4.22–11.78). In the five RCTs ( n = 283) comparing 2 g/h vs 1 g/h maintenance regimens, no case of eclampsia was reported with either regimen, and maternal side effects were significantly higher in the 2 g/h group (71% vs 42%, OR 1.69, 95% CI: 1.06–2.71). In conclusion, magnesium sulfate maintenance regimen of 1 g/h seems as effective as the 2 g/h regimen for the prevention of eclampsia, with decreased incidence of maternal side effects.

Subjects

MeSH terms (MEDLINE)

Magnesium SulfateEclampsiaAnticonvulsantsHumansFemalePregnancyRandomized Controlled Trials as Topic

Substances

Magnesium SulfateAnticonvulsants

Authors and institutions

  • Department of Woman and Child Health and Public Health Sciences, Fondazione Policlinico A. Gemelli IRCSS, Catholic University of the Sacred Heart, Rome, Italy.
  • Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.
  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

ORCID profiles: Alessandro Petrecca, Tullio Ghi

Cite

APA

Petrecca, A., Bina, B., Ghi, T., & Berghella, V. (2026). 1 g/h magnesium sulfate maintenance for eclampsia prevention is enough. Acta Obstetricia et Gynecologica Scandinavica, 105(5), 771-777. https://doi.org/10.1111/aogs.70205

Vancouver

Petrecca A, Bina B, Ghi T, Berghella V. 1 g/h magnesium sulfate maintenance for eclampsia prevention is enough. Acta Obstetricia et Gynecologica Scandinavica. 2026;105(5):771-777. doi:10.1111/aogs.70205

BibTeX
@article{Petrecca2026,
  author = {Petrecca, Alessandro and Bina, Benedetta and Ghi, Tullio and Berghella, Vincenzo},
  title = {1 g/h magnesium sulfate maintenance for eclampsia prevention is enough},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2026},
  volume = {105},
  number = {5},
  pages = {771--777},
  doi = {10.1111/aogs.70205}
}
Start for free →